- Home
- CIO vs PYXS Comparison
CIO vs PYXS Comparison
Compare CIO & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIO
- PYXS
- Stock Information
- Founded
- CIO 2013
- PYXS 2018
- Country
- CIO Canada
- PYXS United States
- Employees
- CIO N/A
- PYXS N/A
- Industry
- CIO Real Estate Investment Trusts
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- CIO Real Estate
- PYXS Health Care
- Exchange
- CIO Nasdaq
- PYXS Nasdaq
- Market Cap
- CIO 230.9M
- PYXS 210.4M
- IPO Year
- CIO 2014
- PYXS 2021
- Fundamental
- Price
- CIO $4.88
- PYXS $4.19
- Analyst Decision
- CIO
- PYXS Strong Buy
- Analyst Count
- CIO 0
- PYXS 7
- Target Price
- CIO N/A
- PYXS $9.57
- AVG Volume (30 Days)
- CIO 199.8K
- PYXS 706.7K
- Earning Date
- CIO 10-31-2024
- PYXS 11-12-2024
- Dividend Yield
- CIO 8.18%
- PYXS N/A
- EPS Growth
- CIO N/A
- PYXS N/A
- EPS
- CIO N/A
- PYXS N/A
- Revenue
- CIO $173,528,000.00
- PYXS $16,146,000.00
- Revenue This Year
- CIO N/A
- PYXS N/A
- Revenue Next Year
- CIO $0.25
- PYXS N/A
- P/E Ratio
- CIO N/A
- PYXS N/A
- Revenue Growth
- CIO N/A
- PYXS N/A
- 52 Week Low
- CIO $4.02
- PYXS $1.35
- 52 Week High
- CIO $6.71
- PYXS $6.85
- Technical
- Relative Strength Index (RSI)
- CIO 32.25
- PYXS 56.86
- Support Level
- CIO $5.01
- PYXS $3.88
- Resistance Level
- CIO $5.43
- PYXS $5.39
- Average True Range (ATR)
- CIO 0.21
- PYXS 0.31
- MACD
- CIO -0.04
- PYXS 0.04
- Stochastic Oscillator
- CIO 7.38
- PYXS 34.43
About CIO City Office REIT Inc.
City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. The company owns office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.